XML 15 R8.htm IDEA: XBRL DOCUMENT

Other Current Assets	3 Months Ended
Other Current Assets	Mar. 31, 2012
Other Current Assets	Note 3. Other Current Assets Other current assets at March 31, 2012 include prepaid reagents and supplies amounting to $796,154 that will be used in the Company’s planned clinical study. Opexa expects to amortize these prepaid reagents and supplies to research and development costs upon initiation of the planned clinical study.